Form 4 Filing for BIOADAPTIVES, INC.

Mark P. Frissora, a director at BIOADAPTIVES, INC., acquired 15,625 shares of Series D Convertible Preferred Stock on October 1, 2026. This acquisition was part of compensation for board services. The preferred stock is convertible into common stock at a 100:1 ratio, subject to a 4.9% beneficial ownership limitation. The preferred stock grants 100 votes per share on company matters. The transaction details indicate a price of $0 per share, with a footnote clarifying this relates to compensation. Following the transaction, Mr. Frissora holds 155,265 shares of Series D Convertible Preferred Stock.